- 2 days & nights inpatient stay
- 11 quick follow-up appointments
This clinical trial has been approved by an independent ethics committee.
About the study
We need healthy males for a medication comparison study.
This study is looking at a medication for the potential treatment for paroxysmal nocturnal haemoglobinuria (PNH). This is a rare disorder that causes red blood cells to break down sooner than they should. This is a biosimilar study. This means that the medication being tested is an almost identical version of a medication that has already been approved called Soliris®.
At this stage of testing we are not looking at whether it will have any therapeutic value, so we require healthy males to participate.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at firstname.lastname@example.org quoting “Similar Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!